Package 41163-593-71

Brand: equaline naproxen sodium pm

Generic: diphenhydramine hydrochloride, naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 41163-593-71
Digits Only 4116359371
Product NDC 41163-593
Description

1 BOTTLE in 1 CARTON (41163-593-71) / 50 TABLET, FILM COATED in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2022-03-25
Brand equaline naproxen sodium pm
Generic diphenhydramine hydrochloride, naproxen sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "26bb9c64-c1af-409a-852e-3b2084de8b6a", "openfda": {"unii": ["TC2D6JAD40", "9TN87S3A3C"], "rxcui": ["1550957"], "spl_set_id": ["ed7bfa3f-4972-4ab6-9f0c-0873a11571a9"], "manufacturer_name": ["United Natural Foods, Inc. dba UNFI"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (41163-593-71)  / 50 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "41163-593-71", "marketing_start_date": "20220325"}], "brand_name": "equaline naproxen sodium pm", "product_id": "41163-593_26bb9c64-c1af-409a-852e-3b2084de8b6a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "41163-593", "generic_name": "diphenhydramine hydrochloride, naproxen sodium", "labeler_name": "United Natural Foods, Inc. dba UNFI", "product_type": "HUMAN OTC DRUG", "brand_name_base": "equaline naproxen sodium pm", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA208499", "marketing_category": "ANDA", "marketing_start_date": "20191217", "listing_expiration_date": "20261231"}